These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3118272)

  • 21. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease.
    Marschner JA; Mulay SR; Steiger S; Anguiano L; Zhao Z; Boor P; Rahimi K; Inforzato A; Garlanda C; Mantovani A; Anders HJ
    Front Immunol; 2018; 9():2173. PubMed ID: 30319631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis; relationship to citrate and calcium excretion.
    Parfitt AM
    Arch Intern Med; 1969 Dec; 124(6):736-40. PubMed ID: 5353483
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
    Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
    J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic fibrosis and calcium oxalate nephrolithiasis.
    Chidekel AS; Dolan TF
    Yale J Biol Med; 1996; 69(4):317-21. PubMed ID: 9273985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exacerbation of nephrolithiasis by a carbonic anhydrase inhibitor.
    Wallace MR; MacDiarmid J; Reeder J
    N Z Med J; 1974 Feb; 79(509):687-90. PubMed ID: 4522951
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduction of elevated plasma oxalic acid by pyridoxine therapy in patients on RDT.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H
    Proc Eur Dial Transplant Assoc; 1983; 19():308-12. PubMed ID: 6878246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrolithiasis and nephrocalcinosis with calcium oxalate crystals in the kidneys and other organs; report of two cases.
    LUND T; RESKE-NIELSEN E
    Acta Pathol Microbiol Scand Suppl; 1956; 39(Suppl 111):102-4. PubMed ID: 13372279
    [No Abstract]   [Full Text] [Related]  

  • 30. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrolithiasis and nephrocalcinosis with calcium oxalate crystals in the kidneys and other organs; report of two cases.
    LUND T; RESKE-NIELSEN E
    Acta Pathol Microbiol Scand; 1956; 38(5):353-63. PubMed ID: 13339329
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of piridoxilate, a glyoxylic acid derivative, on the energy metabolism of the heart.
    Otorii T; Katano Y; Takeda K; Imai S
    Jpn Heart J; 1980 Nov; 21(6):845-57. PubMed ID: 7463722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential for bilateral nephrectomy to reduce oxalate release after combined liver and kidney transplantation for primary hyperoxaluria type 1.
    Mizusawa Y; Parnham AP; Falk MC; Burke JR; Nicol D; Yamanaka J; Lynch SV; Strong RW
    Clin Transplant; 1997 Oct; 11(5 Pt 1):361-5. PubMed ID: 9361924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experimentation of piridoxilate in the treatment of leg ulcer].
    Huriez C; Faustin JM
    Lille Med; 1970 Mar; 15(3 Suppl 2):422-4. PubMed ID: 5421803
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of calcium oxalate stones.
    Hanson KA
    Clin Excell Nurse Pract; 2001; 5(1):21-5. PubMed ID: 11154390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ion binding by small molecular weight substances (1,000-10,000 daltons) in urine.
    Nicar MJ; Holt K; Pak CY
    Invest Urol; 1980 Sep; 18(2):162-4. PubMed ID: 7410030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study of piridoxilate in deficit syndromes].
    Morin JY; Holleville P
    Ann Med Psychol (Paris); 1970 Feb; 1(2):297-300. PubMed ID: 5420927
    [No Abstract]   [Full Text] [Related]  

  • 40. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.